University of California, San Diego | UCSD AntiViral Research Center

Research site

(Unclaimed)

Location

220 Dickinson Street, Suite A, San Diego, California, United States of America

Site insights

Top conditions

Top treatments

Ribavirin

Sofosbuvir

Lenacapavir

Daclatasvir

Tenofovir Disoproxil Fumarate

Interferon

Emtricitabine

TDF

BMS-790052

PrEP

Parent organization

This site is a part of University of California, San Diego

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 32 total trials

A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

This study is designed to find out how well the COVID-19 vaccine protects people 50 to 64, who don't have any serious health problems, compared to a...

Enrolling

COVID-19

SARS-COV-2 Infection

Biological: Placebo

Biological: BNT162b2 Vaccine

Digital Health Feedback System (DHFS) for Longitudinal Monitoring of ARVs Used in HIV Pre-exposure Prophylaxis (PrEP)

This study uses an ingestion sensor and a wearable sensor (worn as a patch on the skin), which are new Proteus Digital Health (PDH) technologies appr...

Active, not recruiting

HIV Prevention

Device: Digital Health Feedback System

Digital Health Feedback System for Longitudinal Measurement of Medication Adherence During Anti-Retroviral (ARV)Therapy

This study uses an ingestion sensor and a wearable sensor (worn as a patch on the skin), which are new Proteus Digital Health (PDH) technologies appr...

Active, not recruiting

HIV

Device: Digital Health Feedback System

Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People Who Inject Drugs (HPTN 103) (PURPOSE 4)

The goals of this clinical study are to look at how lenacapavir (LEN) passes through the body and to assess the safety of LEN and emtricitabine/tenof...

Active, not recruiting

Pre-Exposure Prophylaxis of HIV Infection

Drug: Lenacapavir Injection

Drug: Lenacapavir Tablet

Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102) (PURPOSE 3)

The goal of this clinical study is to look at how lenacapavir (LEN) passes through the body and to assess the safety of LEN and emtricitabine/tenofov...

Active, not recruiting

Pre-Exposure Prophylaxis of HIV Infection

Drug: Lenacapavir Injection

Drug: Lenacapavir Tablet

Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP) (PURPOSE 365)

The goal of this clinical study is to learn more about the study drug lenacapavir (LEN), safety, tolerability, and pharmacokinetics (how LEN is absor...

Enrolling

HIV Pre-exposure Prophylaxis

Drug: Lenacapavir Tablet

Drug: Lenacapavir Injection